MADASH

ADASH, LLC is a consulting company managed by Dr. Eyal S.Ron. MADASH helps pharmaceutical and biotechnology companies to move their product candidates rapidly and cost - efficiently from research and development into clinical trials. Our services significantly enhance the value of your drug candidate. By providing expertise and a wide network of resources, we help you enhance the overall value of your product and company without building costly infrastructure.
Dr. Eyal S. Ron has over 25 years of experience in the development of drugs, biomaterials and drug delivery systems. He has a record of accomplishments for the creation of effective infrastructure for growth. Dr. Ron is effective in combining science with innovative business strategies, having developed and implemented the scientific, regulatory and clinical strategy for several companies. He has in-depth understanding of total development process including project management, clinical trials, regulatory, formulation, drug delivery, QC and manufacturing scale-up. He has contributed to the formation of Cerebrotec, Combinent Biomedical Systems, eNOS Pharmaceuticals, Focal, GelMed/Gel Sciences, Gelesis, InfiMed, Palmetto Pharmaceuticals, Pharmedica and Sensei Biomaterials.

Additionally, Dr. Ron is actively involved (as an acting CTO, SAB member or as a director) in a variety of projects directed at slow release and controlled release of high MW and low MW drugs from polymeric systems.